National Drug Scheduling Advisory Committee Meeting June 8-9, 2014
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for June 8-9, 2014.
Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules
Information for students:
Individuals wishing to pursue courses as part of the National Pharmacy Technician Bridging Education Program can now find information such as course dates, registration deadlines and educational institution contact information on the Course and PLAR Schedules page.
Please note, this section will be updated periodically as the information becomes available.
Welcome to the Winnipeg Technical College - a newly authorized educational institution for the delivery of the program
NEW: Spring 2014 schedules now available*.
* Registration deadlines for all institutions are available on the Course and PLAR Schedules page.
Registration for all courses is conducted directly with the educational institution offering the program.
NDSAC Meeting of March 9-10, 2014
A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on March 9-10, 2014 to consider the following matters:
- Request for Schedule III status for minoxidil foam 5% for topical use
- Request for Unscheduled status for diclofenac and its salts, when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less diclofenac for not more than 7 days
Potentially dangerous unauthorized drugs seized from “SVN FUEL” stores in B.C.
Four unauthorized drugs being sold at two SVN FUEL stores - one in Burnaby and one in Coquitlam, B.C. - were seized by Health Canada as they contain ingredients that are potentially dangerous to the health of consumers.
Health Canada Advisory
Health Professional and Public Communication
Amplatzer Septal Occluder - Risk of Erosion - St. Jude Medical Canada, Inc.
St. Jude Medical Inc., in collaboration with Health Canada is advising Canadians of the risk of tissue erosion associated with the implantation of the Amplatzer Septal Occluder (ASO). Erosion is a rare but potential life threatening event which may be caused by the ASO rubbing against the wall of the heart or surrounding structures.
Health Canada Health Professional Communication
Health Canada Public Communication
Notice to Hospitals
Clinimix - 5% TRAVASOL Amino Acid Injection WITH Electrolytes in 16.6% Dextrose Injection, 1 L - Recall Due to Particulate Matter Found in the Solution - Baxter Corporation
There is potential for particulate matter to be present in Clinimix 5% TRAVASOL Amino Acid Injection WITH Electrolytes in 16.6% Dextrose Injection. Baxter is advising all users to immediately locate and remove the affected lots from use. Return all affected products to Baxter.
Health Canada Notice to Hospitals